Lung cancer patient becomes tumor-free after treatment with selenite
A patient with advanced, treatment-resistant lung cancer became tumor-free after treatment with the selenium compound selenite. This is shown in a new study from Karolinska University Hospital and Karolinska Institutet published in the journal Oncology and Therapy as a case report. The findings may contribute to increased knowledge about selenite as a possible cancer treatment.
A patient with advanced, treatment-resistant lung cancer was found to be tumor-free after receiving treatment with the selenium compound selenite, according to a new study published in the journal Oncology and Therapy. The case report, authored by researchers from Karolinska University Hospital and Karolinska Institutet, highlights the potential of selenite as a cancer treatment.
Following the treatment, the patient's tumor vanished and remained absent for a decade. The researchers also noted a significant decrease in the tumor marker sPD-L1 during the course of treatment, suggesting that selenite may have helped activate the patient's immune system against the tumor. However, the researchers emphasize that the study involves only one patient, and further studies involving larger groups are needed to confirm these findings.
Ola Brodin, an associate professor at Karolinska Institutet, states that the results are promising and that the researchers are planning a larger study to investigate selenite as a treatment option for advanced cancer patients. The study authors note that selenite is inexpensive, has no significant side effects, and is environmentally friendly, making it a potentially equitable and accessible treatment option for patients worldwide.
Written by urgent.news from Medical Xpress's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
